New drug aims to stop deadly clots in cancer patients
NCT ID NCT07410117
Summary
This study is testing an experimental drug, REGN7508, to see if it can safely prevent blood clots in people with advanced solid tumors who are receiving cancer treatment. About 860 participants will be randomly assigned to receive either the study drug or a placebo (inactive substance) to compare their effectiveness. The main goals are to see if the drug reduces the risk of blood clots and to monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER-ASSOCIATED THROMBOSIS (CAT) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bioresearch Partner- Hialeah Hospital
RECRUITINGHialeah, Florida, 33013, United States
-
El Paso Medical Research Institute (Medresearch Inc)
RECRUITINGEl Paso, Texas, 79902, United States
-
LTD High Technology Hospital Medcenter
RECRUITINGBatumi, Adjara, 6000, Georgia
-
Llc Todua Clinic
RECRUITINGTbilisi, 0112, Georgia
-
Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
RECRUITINGTbilisi, 0144, Georgia
Conditions
Explore the condition pages connected to this study.